Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 102.05

+0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (737)	10/1/1998 2:18:00 AM
From: Vector1	Read Replies (1) of 3202

Harold, i think INCY is an excellent investment at current levels. The price has gotten crushed because the street believes that there is increasing competition (particularly PNK's JV with Craig Ventor)and as a result INCY's database will be less valuable. In additon the Street is concerned that INCY's new venture to create a detailed map of Single Nucleotide Polymorphisms will cost a lot of money and hurt near term earnings. INCY's is planning on creating a tracking stock for this venture and I believe a substantial portion of the funding for the tracking stock will be made up of Pharma companies in INCY's current syndicate. Tracking stocks have become a big negative for biotech companies thanks to Genzyme. I added to my personal position at $20 and may buy more. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next